In-Patient PPS, "Inherent Reasonableness" Rulemaking Changes Sought
This article was originally published in The Gray Sheet
Devices used in low-volume medical procedures should be guaranteed adequate payments under HCFA's implementation of an in-patient prospective payment system for new technologies, AdvaMed is urging the agency.
You may also be interested in...
Legislation should be enacted to allow the Health Care Financing Administration to negotiate preferred providers and fixed-price packages for bypass surgery for Medicare patients, the HHS Office of the Inspector General concludes in "The 2001 Red Book," a list of cost-saving recommendations that have yet to be implemented.
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.